Vallee F, Karaveg K, Herscovics A, Moremen K W, Howell P L
Program in Structural Biology and Biochemistry, Research Institute, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
J Biol Chem. 2000 Dec 29;275(52):41287-98. doi: 10.1074/jbc.M006927200.
Endoplasmic reticulum (ER) class I alpha1,2-mannosidase (also known as ER alpha-mannosidase I) is a critical enzyme in the maturation of N-linked oligosaccharides and ER-associated degradation. Trimming of a single mannose residue acts as a signal to target misfolded glycoproteins for degradation by the proteasome. Crystal structures of the catalytic domain of human ER class I alpha1,2-mannosidase have been determined both in the presence and absence of the potent inhibitors kifunensine and 1-deoxymannojirimycin. Both inhibitors bind to the protein at the bottom of the active-site cavity, with the essential calcium ion coordinating the O-2' and O-3' hydroxyls and stabilizing the six-membered rings of both inhibitors in a (1)C(4) conformation. This is the first direct evidence of the role of the calcium ion. The lack of major conformational changes upon inhibitor binding and structural comparisons with the yeast alpha1, 2-mannosidase enzyme-product complex suggest that this class of inverting enzymes has a novel catalytic mechanism. The structures also provide insight into the specificity of this class of enzymes and provide a blueprint for the future design of novel inhibitors that prevent degradation of misfolded proteins in genetic diseases.
内质网(ER)I类α1,2-甘露糖苷酶(也称为ERα-甘露糖苷酶I)是N-连接寡糖成熟和内质网相关降解过程中的关键酶。去除单个甘露糖残基作为一种信号,将错误折叠的糖蛋白靶向蛋白酶体进行降解。已测定了人ER I类α1,2-甘露糖苷酶催化结构域在存在和不存在强效抑制剂基夫内新和1-脱氧甘露基野尻霉素时的晶体结构。两种抑制剂都在活性位点腔底部与蛋白质结合,必需的钙离子与O-2'和O-3'羟基配位,并以(1)C(4)构象稳定两种抑制剂的六元环。这是钙离子作用的首个直接证据。抑制剂结合时缺乏主要构象变化以及与酵母α1,2-甘露糖苷酶酶-产物复合物的结构比较表明,这类转化酶具有一种新的催化机制。这些结构还为这类酶的特异性提供了见解,并为未来设计新型抑制剂提供了蓝图,这些抑制剂可防止遗传性疾病中错误折叠蛋白质的降解。